McDonnell Boehnen Hulbert & Berghoff LLP partner Dr. Kevin E. Noonan is quoted in a June 17, 2013 edition of Law360.com in an article entitled, “Lawyers Comment On High Court’s Pay-For-Delay Decision.” The U.S. Supreme Court ruled June 17, 2013 that brand-name drugmakers can be sued for paying generic-drug manufacturers to delay the release of low-cost versions of blockbuster medicines, overturning an Eleventh Circuit finding that the agreements were generally legal. Here, attorneys tell Law360 why the 5-3 decision in Federal Trade Commission v. Actavis Inc. is significant. View the article